Financials

News Ideas Discussions Technicals Forecast Seasonals Options

RIGL fundamentals

The current financial position of Rigel Pharmaceuticals, Inc.

Total assets of RIGL for Q2 25 is 206.74 M USD, 17.48% more than the previous Q1 25. And total liabilities decreased by 20.71% in Q2 25 to 124.8 M USD.

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Total assets

Total liabilities

Currency: USD